Infertility Treatment Devices Market Size - By Type (Sperm Separation Devices, Ovum Aspiration Pumps, Sperm Analyzer Systems, Micromanipulator Systems, Incubators, Cryosystems, Imaging Systems, Microscopes), By End-use – Global Forecast to 2032

Infertility Treatment Devices Market Size

Infertility Treatment Devices Market size was valued at USD 319.3 million in 2022 and is estimated to account for USD 695.8 million by 2032.
 

Infertility treatment devices are used to diagnose, treat, or aid in the treatment of infertility in individuals having trouble conceiving. These devices are used in a variety of procedures and therapies that target the root causes of infertility or support assisted reproductive technologies (ART). Further, the development of in vitro fertilization (IVF) and other assisted reproductive technologies (ART) have raised demand for infertility treatment devices, thereby predicted to stimulate market share.
 

Infertility is a multidimensional problem with economic, social, and cultural implications. Growing awareness regarding availability of infertility treatment devices globally in recent years will act as a driving factor for the industry expansion. Various government and private organizations aim at promoting awareness about infertility, surrogacy, and IVF procedures and improving infertility-related services globally. For instance, the National Infertility Awareness Week (NIAW) is a campaign intended to increase the awareness rate concerning infertility. In addition, growing understanding among the population base about the success rate of IVF procedures will further aid in market expansion.
 

COVID-19 Impact

The global pandemic affected millions of people worldwide, resulting into high mortality. The pandemic negatively impacted the infertility treatment devices market due to mobility constraints and safety concerns during several fertility procedures. Several organizations have undertaken initiatives to maintain reproductive health standards. Many infertility clinics were temporarily suspended, or their operations were limited during the peak of pandemic to prioritize urgent care and minimize the risk of COVID-19 transmission. This disruption resulted in the delay or cancellation of fertility treatment cycles, including the use of infertility treatment devices. Moreover, decline in the number of ART procedures at the beginning of COVID-19 affected the product demand in fertility clinics.
 

Infertility Treatment Devices Market Trends

Increase in the prevalence rate of infertility is attributed to various factors such as obesity and adoption of unhealthy dietary habits including excessive alcohol consumption & smoking, recreational drug consumption, among others. In addition, exposure to environmental pollutants and toxins can be extremely harmful to gametes (sperm and eggs), leading to infertility. Moreover, the rising infertility cases among women are owing to several disorders of the genital organs, growing age at conception, endocrine disorders which causes imbalances of reproductive hormones.
 

For instance, according to the American Pregnancy Association, nearly 30% of male population suffer from infertility and contributes to around one-fifth of infertility cases. Additionally, as per data from the Centers for the Disease Control and Prevention (CDC), around 12.1% of women, aged between 15 to 44 years are unable to conceive. Additionally, 6.7% of married women aged 15 to 44 years are infertile. Thus, the rising prevalence of infertility across the population base will stimulate market progress.
 

Infertility Treatment Devices Market Analysis

The infertility treatment devices market by type is categorized into sperm separation devices, ovum aspiration pumps, sperm analyzer systems, micromanipulator systems, incubators, cryosystems, imaging systems, microscopes, and others. The sperm separation devices segment garnered USD 55.4 million revenue size in the year 2022. Sperm separation devices are used in assisted reproductive treatments such as artificial insemination and in vitro fertilization (IVF). The upsurge can be attributed to its capacity to separate highly mobile sperm with competent DNA integrity from a sample of semen. Additionally, the sperm separation process removes sperms with defects such as bigger heads or twisted necks. Sperm separation arrays allow only the healthiest and most robust sperm to pass through.
 

Based on end-use, the infertility treatment devices market is segmented into fertility clinics, hospitals & other healthcare facilities, and clinical research institutes. The fertility clinics segment accounted for over 80% business share in the year 2022 and is anticipated to witness highest growth during the forecast period. Fertility clinics have enhanced their infrastructure along with strengthening the portfolio including infertility services, thereby is anticipated to impel the segment growth. Adoption of several procedures is considerably high in fertility clinics due to substantial performance of surrogacy, IVF, procedures in facilities, thus escalating the demand for infertility treatments. Moreover, expanding number of specialized centers in emerging countries and rapid integration of advanced technologies at such facilities will propel industry demand.
 

U.S. infertility treatment devices market accounted for USD 120.4 million revenue size in 2022 and is predicted to witness substantial market growth over the analysis timeline. Advancements in infertility treatment devices, favourable regulatory environment, and growing healthcare expenditure are the key driving factors for the U.S. market trends. Additionally, the presence of non-tax agencies that provide financial aid, the prevalence of charity trusts that provide funds for infertility treatments to infertile couples, and the significant presence of well-established market players, particularly in North America, will encourage market expansion in the upcoming years.
 

Infertility Treatment Devices Market Share

Some of the prominent market participants operating in the infertility treatment devices industry include:

• CooperSurgical In
• Vitrolife AB
•  Cook Medical Inc 
• Thermo Fisher Scientific Inc
•  Merck KGaA
•  Eppendorf AG
•  Rocket Medical Plcs
•  Art Biotech Pvt Ltd
•  LabIVF Asia Pte Ltd
•  Hamilton Thorne Inc
• IVFtech ApS
•  Dxnow (ZyM?t Fertility, Inc.),

These market players are undertaking several growth strategies including partnerships, collaborations, acquisitions & mergers, and new product development & launches to strengthen their product portfolio as well as gain a competitive edge over others.
 

Infertility Treatment Devices Industry News:

• In December 2022, Hamilton Thorne Ltd. acquired Microptic, S.L. The acquisition expands the company's expertise in the artificial intelligence-enabled product range and enhances its position in the computer-assisted semen analysis for IVF clinics market.
   
• In July 2022, Cellink collaborated with Spermosens, Malmö University, and Saint Louis University (SLU). The goal of the partnership was to create a tool that could detect male infertility. Such initiative enabled in industry expansion.
   

Infertility treatment devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Type (USD Million & Units)

• Sperm separation devices
• Ovum aspiration pumps
• Sperm analyzer systems
• Micromanipulator systems
• Incubators
• Cryosystems
• Imaging systems
• Microscopes
• Others

By End-use (USD Million)

• Fertility clinics
• Hospitals & other healthcare facilities
• Clinical research institutes

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Switzerland
  • The Netherlands
  • Denmark
  • Poland
  • Sweden
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • New Zealand
  • Thailand
  • Vietnam
  • Indonesia
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Turkey